Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?

Background: Annual MRI screening is associated with a significant reduction in advanced-stage breast cancer diagnosis in BRCA1/2 mutation carriers. The impact that early detection has on subsequent oncological treatment is less frequently reported. In this study we compared disease stage and therape...

Full description

Bibliographic Details
Main Authors: Rinat Bernstein-Molho, Bella Kaufman, Merav A. Ben David, Miri Sklair-Levy, Dana Madoursky Feldman, Dov Zippel, Yael Laitman, Eitan Friedman
Format: Article
Language:English
Published: Elsevier 2020-02-01
Series:Breast
Subjects:
BRCA1 BRCA2
Surveillance
Early diagnosis
Intensive screening
Risk-reducing surgeries
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977619305831

Internet

http://www.sciencedirect.com/science/article/pii/S0960977619305831

Similar Items